Determination of mianserin in human plasma by gas--liquid chromatography. 1982

G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette

The authors describe a method for the plasma determination of mianserin by gas--liquid chromatography (GLC), using cyproheptadine as an internal standard. After extraction from 2 ml of plasma by a hexane:isoamyl alcohol (99:1, vol/vol) mixture and its purification by reextraction, the mianserin is determined by GLC, using a glass column packed with 3% OV1 on Gas-Chrom Q, and a nitrogen-sensitive detector. Since the between-day coefficient of variation (n = 15) is less than 8%, this technique appears to be sufficiently reproducible for routine determination in therapeutic concentrations (detection limit with accuracy = 2.5 microgram/L). As an example, the authors describe the time variations of the plasma concentration of mianserin after a first-dose ingestion of 30 mg. Preliminary studies of kinetic parameters are determined in 11 adult patients following a single oral dose (30 mg of mianserin).

UI MeSH Term Description Entries
D008803 Mianserin A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. Lerivon,Mianserin Hydrochloride,Mianserin Monohydrochloride,Org GB 94,Tolvon,Hydrochloride, Mianserin,Monohydrochloride, Mianserin
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
October 1985, Journal of chromatography,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
April 1969, Analytical biochemistry,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
May 1982, Journal of chromatography,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
July 1987, Revista medica de Chile,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
January 1971, Lipids,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
August 1982, Journal of pharmaceutical sciences,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
January 1983, Journal of pharmaceutical sciences,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
March 1981, Journal of chromatography,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
March 1977, Journal of chromatography,
G F Lachâtre, and G S Nicot, and L J Merle, and J P Valette
January 1980, Journal de pharmacie de Belgique,
Copied contents to your clipboard!